In summary, FGF-21 exhibits remarkable biological efficacy in reducing blood glucose, alleviating inflammation, and ameliorating peripheral nerve injuries, promising to serve as a biomarker and therapeutic target for diabetes management. This evidence concerns the gene FGF21 and diabetes mellitus.